Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study (European Heart Journal, 2021)

(untitled) - Banning, AP; Serruys, P; De Maria, GL; Ryan, N; Walsh, S; Gonzalo, N; Jan van Geuns, R; Onuma, Y; Sabate, M; Davies, J; Lesiak, M; Moreno, R; et al.